EnWave Reports 2025 Second Quarter Consolidated Interim Financial Results

May 22, 2025

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2025.

Toutes les valeurs sont exprimées en milliers et en dollars canadiens, sauf indication contraire.

  • Reported revenue for Q2 2025 of $3,689, an increase of $3,026 relative to the comparable period in the prior year. The increase was primarily related to a large-scale machine sale and the commissioning of two small-scale machines.
  • Reported royalty revenues for Q2 2025 of $474, an increase of $60 relative to the comparable period in the prior year. Royalties grew due to increased royalty partners, product sales, and partner production for the quarter.
  • Gross margin for the three months ending Q2 2025 was 33% compared to (25)% for the three months ending Q2 2024. The increase in margin was a result of higher machine sales, royalties, and tolling revenue for the quarter.
  • Reported an increase in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $10 for Q2 2025 relative to the comparable period in the prior year, with the increase primarily related to recruitment fees.
  • Reported Adjusted EBITDA(1) income for Q2 2025 of $112, an increase of $1,380 from the comparable period in the prior year.

Performance financière consolidée :

($ ‘000s)Three months March 31, Six months ended March 31,
20252024Change % 20252024Change %
Revenues3,689663456% 4,8661,925153%
Direct costs(2,480) (830)199% (3,317) (1,859)78%
   Gross margin1,209(167)(824%) 1,549662,247%
        
Operating expenses       
General and administration5855654% 1,0091,077(6%)
Sales and marketing436440(1%) 92279117%
Research and development378384(2%) 736785(6%)
 1,3991,3891% 2,6672,6531%
Net loss – continuous operations(362)(1,559)77% (1,300)(2,703)52%
Net income (loss) – discontinued operations1,126148661% 1,118(3)(37367%)
Adjusted EBITDA(1) income (loss)112(1,268)(109%) (523)(2,024)(74%)
Income (Loss) per share:       
Continuous operations – basic and diluted   $ 0.00$ (0.01)  $ (0.01)$ (0.02) 
Discontinued operations – basic and diluted   $ 0.01$ 0.00    $ 0.01$ 0.00 
Basic and diluted   $ 0.01$ (0.01)    $ 0.00$ (0.02) 

Note: (1) Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net

Key Financial Highlights for the Six Months Ended March 31, 2025 (expressed in 000’s)

  • Reported revenue of $4,866, an increase of $2,941 relative to the comparable period in the prior year. The increase was primarily related to additional machine sales. 
  • Reported Royalty revenues of $1,033, an increase of $139 or 16% relative to the comparative period in the prior year. Royalties grew due to increased royalty partners, product sales, partner production, and exclusivity payments.
  • Reported an increase in SG&A costs of $14 for the six months ending March 31, 2025, relative to the comparable period in the prior year, with the increase primarily related to tradeshow attendance and recruitment fees offset by reduced legal costs associated with the capitalization of the Term Loan and Credit facility issuance costs.
  • Reported an Adjusted EBITDA(1) loss of $523 for the six months ended March 31, 2025, an increase of $1,501 from the comparable period in the prior year.

Significant Corporate Accomplishments in Q2 2025 and Subsequently:

  • Signed a Technology Evaluation and License Option Agreement with Solve Solutions LTDA of Brazil.
  • Signed a License Agreement Amendment with BranchOut Food Inc. for the exclusive rights to produce dried blueberry products using EnWave’s REVTM technology in Peru.
  • Signed a License Agreement Amendment with Patatas Fritas Torres S.L. of Spain to expand the product portfolio to focus on commercializing healthy, protein-rich snack products.
  • Signed an Equipment Purchase Agreement and License Amendment with Sprouted Proteins for a 10kW REV™ machine and the grant of exclusive rights to produce certain starch-based snack products.
  • Signed an Equipment Purchase Agreement and Commercial Licence Agreement with Hokkai Yamato Foods for a 10kW REVTM  machine.
  • Signed a Master Service Agreement and First Work Order with Bio Technique LLC to evaluate EnWave’s REVTM dehydration technology.
  • Signed an Equipment Purchase Agreement and Licence Agreement Amendment with MicroDried® for a 60kW REV™ machine and the exclusive rights to use REVTM technology for apple ingredient production in Washington, Oregon, and Idaho.
  • Received the Second Progress Payment related to the Equipment Purchase Agreement with Procescir S.A. de C.V. of Mexico for 120kW Radiant Energy Vacuum Machinery.
  • Signed a License Agreement Amendment with Creations Foods US Inc. for an additional right to produce dried cheese snacks for pet treat applications on a non-exclusive basis in the United States. 
  • The Company recognized a $836 USD tax refund for NutraDried during the quarter in discontinued operations.  The tax refund was for the Employee Retention Tax Credit which is a refundable tax credit from the United States government for businesses that were affected during the COVID-19 pandemic.  The Company does not expect to receive any additional tax refunds or credits related to NutraDried.
  • The Company appointed its first international Business Development Manager, based in the Netherlands. This new Business Development Manager will play a pivotal role in strengthening the Company’s international presence and accelerating growth in the European market.
  • Subsequent to the quarter, the Company repurchased a 10 kW REV™ machine and 120kW REV™ machine from an Illinois, U.S. based cannabis company. The transaction increases inventory levels and strengthens the Company’s position to deliver on partnership opportunities, expediting the fulfillment and revenue recognition of prospective REV™ machine sales.  

Mesures financières non conformes aux IFRS :

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring income and expenses, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

Three months ended March 31Three months ended March 31Six months ended March 31Six months ended March 31
 ($ ‘000s) 20252024 20252024
Net income (loss) after income tax764(1,411)(182)(2,706)
      Amortization and depreciation302288595563
      Stock-based compensation12871271186
      Foreign exchange loss (gain)6(51)(141)(27)
      Finance income(30)(54)(77)(106)
      Finance expense683714063
     Non-recurring (income) expense(11)
   Discontinued operations(1,126)(148)(1,118)3
Adjusted EBITDA112(1,268)(523)(2,024)

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management.  Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca

À propos d'EnWave

EnWave est un leader mondial dans l'innovation et l'application de la déshydratation par micro-ondes sous vide. Depuis son siège à Delta, en Colombie-Britannique, EnWave a développé un solide portefeuille de propriété intellectuelle, perfectionné sa technologie Radiant Energy Vacuum (REV™) et transformé une idée novatrice en une solution de séchage éprouvée, cohérente et évolutive pour les industries alimentaire, pharmaceutique et du cannabis, qui surpasse largement les méthodes de séchage traditionnelles en termes d'efficacité, de capacité, de qualité des produits et de coût.

With more than fifty royalty-generating partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

La stratégie d'EnWave consiste à signer des licences commerciales assorties de redevances avec les producteurs de denrées alimentaires qui souhaitent sécher mieux, plus rapidement et plus économiquement que la lyophilisation, le séchage sur claies et le séchage à l'air, et profiter des avantages suivants : produire de nouveaux produits intéressants, atteindre des niveaux d'humidité optimaux jusqu'à sept fois plus rapidement, et améliorer le goût, la texture, la couleur et la valeur nutritionnelle des produits.

Pour en savoir plus, consultez le site EnWave.net.

EnWave Corporation

M. Brent Charleton, CFA

Président et directeur général

Pour plus d'informations :

Brent Charleton, CFA, président et directeur général au +1 (778) 378-9616
E-mail : bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO at +1 (778) 870-0729
E-mail : dmurray@enwave.net  

Safe Harbour pour les déclarations d'informations prospectives : Ce communiqué de presse peut contenir des informations prospectives basées sur les attentes, les estimations et les projections de la direction. Toutes les déclarations portant sur des attentes ou des projections concernant l'avenir, y compris les déclarations relatives à la stratégie de croissance de la société, au développement de produits, à la position sur le marché, aux dépenses prévues et aux synergies attendues à la suite de la clôture, sont des déclarations prospectives. L'exactitude de toutes les affirmations de tiers mentionnées dans le présent communiqué n'est pas garantie. Toutes les références de tiers à des informations de marché dans ce communiqué ne sont pas garanties comme étant exactes car la société n'a pas effectué la recherche primaire originale. Ces déclarations ne constituent pas une garantie de performance future et impliquent un certain nombre de risques, d'incertitudes et d'hypothèses. Bien que la société ait tenté d'identifier les facteurs importants susceptibles d'entraîner une différence matérielle entre les résultats réels, d'autres facteurs peuvent faire en sorte que les résultats ne soient pas conformes aux prévisions, aux estimations ou aux intentions. Il n'y a aucune garantie que ces déclarations se révèlent exactes, car les résultats réels et les événements futurs pourraient différer sensiblement de ceux prévus dans ces déclarations. En conséquence, les lecteurs ne devraient pas accorder une confiance excessive aux déclarations prévisionnelles.

La Bourse de croissance TSX et son fournisseur de services de réglementation (tel que ce terme est défini dans les politiques de la Bourse de croissance TSX) n'assument aucune responsabilité quant à la pertinence ou à l'exactitude du présent communiqué.